A Decade Later: Persistent Electrolyte Wasting After Cisplatin (KIDNEY WEEK 2026) - Oct 2, 2026 - Abstract #PUB097; "Potassium normalized on spironolactone and Entresto. Amiloride was stopped due to worsened orthostasis and minimal benefit...Potential risk factors include later childhood chemotherapy and concurrent ifosfamide exposure, both present in this case...This case supports long-term monitoring for tubular dysfunction in cisplatin-treated childhood cancer survivors, even with preserved kidney function. Management should include screening for oral magnesium side effects, as diarrhea can limit adherence and require a better-tolerated regimen."
Cardiomyopathy • Hypotension • Infectious Disease • Metabolic Disorders • Osteosarcoma • Sarcoma • Solid Tumor • CST3
|
|
Mariam Alam; Luke Conlon; Sydney Elizabeth Hartsell
|